Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer

CONCLUSION: This short-term ctDNA kinetics assessment may provide predictive information to reflect real-time therapeutic response and lead to effective refinement of regimen in patients with advanced pancreatic cancer undergoing systemic chemotherapy.PMID:38277079 | PMC:PMC10817839 | DOI:10.1007/s00432-023-05594-1

Source: Clin Med Res - January 26, 2024 Category: Research Authors: Hideki Motobayashi Yuji Kitahata Ken-Ichi Okada Motoki Miyazawa Masaki Ueno Shinya Hayami Atsushi Miyamoto Atsushi Shimizu Masatoshi Sato Tomohiro Yoshimura Yuki Nakamura Norio Takemoto Tomoki Nakai Takahiko Hyo Kyohei Matsumoto Hiroki Yamaue Manabu Kawai Source Type: research